Convalife (shanghai) Co., Ltd.
Clinical trials sponsored by Convalife (shanghai) Co., Ltd., explained in plain language.
-
New cancer drug combo enters human testing for Tough-to-Treat tumors
Disease control Not yet recruitingThis study is testing a new drug called CVL006, given in combination with several other cancer therapies, for people with advanced solid tumors that have stopped responding to other treatments. The main goals are to find the safest and most effective dose of the combination and t…
Phase: PHASE1, PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 01:12 UTC
-
New Two-Pronged attack on tough cancers
Disease control Not yet recruitingThis trial is testing a new combination treatment for people with advanced solid tumors that have a specific genetic feature called PTEN loss or low expression. About 180 participants will take a pill called CVL237 along with an immunotherapy injection called serplulimab. The mai…
Phase: PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 01:11 UTC